13D Filing: Aisling Capital III LP and Pernix Therapeutics Holdings Inc. (PTX)

Page 6 of 11

Page 6 of 11 – SEC Filing

CUSIP No. 71426V108
SCHEDULE  13D
Page 6 of 11
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dennis Purcell
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3
SEC USE ONLY
4
SOURCE OF FUNDS
OO
5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
0
8
SHARED VOTING POWER
221,809
9
SOLE DISPOSITIVE POWER
0
10
SHARED DISPOSITIVE POWER
221,809
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
221,809
12
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.9%
14
TYPE OF REPORTING PERSON
IN

Follow Pernix Therapeutics Holdings Inc. (NASDAQ:PTX)

Page 6 of 11